MDGL - AlphaYou

Madrigal Pharmaceuticals, Inc. Revenue Breakdown – XETR:YDO1

NeutralJul 25

Eli Lilly Delay Puts Madrigal Stock In Focus For Obesity Drug Investors

NeutralJul 24

Eli Lilly Delay Puts Madrigal Stock In Focus For Obesity Drug Investors

NeutralJul 23

BofA Securities Maintains Madrigal Pharmaceuticals(MDGL.US) With Hold Rating, Raises Target Price to $553

BullishJul 22

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Leans bullishJul 21

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Leans bullishJul 21

Madrigal New Hires Receive Options With $550.25 Exercise Price

BullishJul 21

Form 4 Madrigal Pharmaceuticals Inc For: 21 July By Investing.com

NeutralJul 21

Madrigal Pharmaceuticals Inc